This issue of Bracco 1 focuses on liver disease. This is evidenced not only by the enormous volume of research, studies, and scientific events, but also by the development of a modern and innovative pharmacology rigorously committed to translating the emerging doctrinal notions in this field into therapeutic practice.
Extent
Quantity:
1
Reference code
Reference code:
b. 2, fasc. 14
Structure
Evolving Chronic Liver Diseases: Early Diagnosis and Timely Treatment by Alfredo Boselli (p. 123-I)
A Conference to Remember (p. 123-I)
A Unified Knowledge (p. 123-I)
The Need for Early Diagnosis or, at Least, Stage Diagnosis (p. 126-I)
Diagnostic Methods (p. 126-I)
Laboratory Tests and the Practical Physician (p. 127-I)
Prognosis and Course (p. 128-I)
Medico-Social Aspects (p. 129-I)
Treatment: of Cirrhosis and E.C.E. (p. 129-I)
Good Reasons for Another, More Appropriate Skepticism (p. 129-I)
Appropriate Experimental Methods Over Time (p. 130-I)
General Methodological Principles to Follow in Drug Experimentation for the Treatment of Liver Diseases Evolving chronic liver disease (p. 131-I)
A panoramic view of drugs for hepatic impairment (p. 132-I)
The reasons for basic hepatic impairment therapy with a tetrahydrofolate and its activators (p. 134-I)
Technical features
20 p. (121 - 140 pp.) : ill. ; 34x16 cm
Notes
Editor-in-Chief: Tullio Bracco
Editor: Ketto Cattaneo
Layout: Mario Scheichenbauer
Drawings and graphics: Lido Picarelli
Printing: Amilcare Pizzi S.p.A.
On the cover: histological picture of a manifest cirrhosis, detail of the complete subversion of the lobular structure with the formation of a pseudolobule
Noted within the issue are advertisements for Merck-Bracco pharmaceutical products featured in the issue: Eparmefolin, Nutrizym
Bi-monthly publication
